title: Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.
abstract: Patients with diabetes frequently exhibit the combined occurrence of hyperglycemia and dyslipidemia. Published data on their coexistence are often controversial. Some studies provide evidence for suboptimal lifestyle and exogenous hyperinsulinism at "mild insulin resistance" in adult diabetic patients as main pathogenic factors. In contrast, other studies confirm that visceral adiposity and insulin resistance are the basic features of dyslipidemia in type 2 diabetes (T2D). The consequence is an excess of free fatty acids, which causes hepatic gluconeogenesis to increase, metabolism in muscles to shift from glucose to lipid, beta-cell lipotoxicity, and an appearance of the classical "lipid triad", without real hypercholesterolemia. Recently, it has been proposed that cholesterol homeostasis is important for an adequate insulin secretory performance of beta-cells. The accumulation of cholesterol in beta-cells, caused by defective high-density lipoprotein (HDL) cholesterol with reduced cholesterol efflux, induces hyperglycemia, impaired insulin secretion, and beta-cell apoptosis. Data from animal models and humans, including humans with Tangier disease, who are characterized by very low HDL cholesterol levels, are frequently associated with hyperglycemia and T2D. Thus, there is a reciprocal influence of dyslipidemia on beta-cell function and inversely of beta-cell dysfunction on lipid metabolism and micro- and macrovascular complications. It remains to be clarified how these different but mutually influencing adverse effects act in together to define measures for a more effective prevention and treatment of micro- and macrovascular complications in diabetes patients. While the control of circulating low-density lipoprotein (LDL) cholesterol and the level of HDL cholesterol are determinant targets for the reduction of cardiovascular risk, based on recent data, these targets should also be considered for the prevention of beta-cell dysfunction and the development of type 2 diabetes. In this review, we analyze consolidated data and recent advances on the relationship between lipid metabolism and diabetes mellitus, with particular attention to the reciprocal effects of the two features of the disease and the development of vascular complications.
authors: Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Italy.
authors: Gianluca
authors: G
authors: Bardini
authors: Carlo M
authors: CM
authors: Rotella
authors: Stefano
authors: S
authors: Giannini
mesh_terms: D000818:Animals; D003920:Diabetes Mellitus / Q000097:blood* / Q000378:metabolism / Q000473:pathology*; D050171:Dyslipidemias / Q000097:blood* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000378:metabolism / Q000473:pathology; D050417:Insulin-Secreting Cells / Q000378:metabolism* / Q000473:pathology*; D008053:Lipid Mobilization
references: Circulation. 2002 Dec 17;106(25):3143-421
references: 12485966
references: Atheroscler Suppl. 2012 Aug;13(1):1-10
references: 22818818
references: Nature. 2002 Jun 13;417(6890):750-4
references: 12066187
references: Eur J Clin Invest. 2002 Feb;32(2):84-92
references: 11895454
references: Physiol Rev. 2013 Jan;93(1):359-404
references: 23303913
references: Diabetologia. 2010 Jun;53(6):1110-9
references: 20229095
references: Diabetes Res Clin Pract. 2001 Feb;51(2):107-14
references: 11165690
references: Biochim Biophys Acta. 2012 May;1821(5):770-7
references: 22001232
references: Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):262-9
references: 21450674
references: J Clin Lipidol. 2012 Mar-Apr;6(2):132-8
references: 22385546
references: J Atheroscler Thromb. 2009 Jun;16(3):292-6
references: 19556721
references: Diabetes Care. 2003 Jan;26(1):16-23
references: 12502653
references: Circulation. 2004 Jul 13;110(2):227-39
references: 15249516
references: N Engl J Med. 2011 Jan 13;364(2):127-35
references: 21226578
references: Curr Opin Lipidol. 2011 Aug;22(4):254-61
references: 21734572
references: Atherosclerosis. 2012 Jun;222(2):567-73
references: 22541874
references: Gene. 2012 Apr 15;497(2):340-3
references: 22326531
references: J Am Coll Cardiol. 2008 Jan 1;51(1):49-55
references: 18174036
references: J Lipid Res. 2010 Aug;51(8):2422-7
references: 20436182
references: Diabetes Care. 2004 Jan;27(1):53-8
references: 14693966
references: Lancet. 1998 Sep 12;352(9131):837-53
references: 9742976
references: J Am Coll Cardiol. 2012 Aug 7;60(6):517-20
references: 22796252
references: Arch Intern Med. 2001 Jun 11;161(11):1413-9
references: 11386890
references: Diabetologia. 2006 May;49(5):1008-16
references: 16518588
references: Diabetologia. 1996 Apr;39(4):453-61
references: 8777995
references: Curr Diab Rep. 2008 Feb;8(1):60-4
references: 18367000
references: JAMA. 2008 Jun 4;299(21):2524-32
references: 18523221
references: Diabetes. 2010 Jul;59(7):1771-9
references: 20393149
references: Clin Chem. 1972 Jun;18(6):499-502
references: 4337382
references: Diabetologia. 2011 Mar;54(3):487-95
references: 21116607
references: Biochem Biophys Res Commun. 2009 Jan 16;378(3):545-50
references: 19056350
references: Diabetes Res Clin Pract. 2013 Jan;99(1):30-8
references: 23137417
references: N Engl J Med. 1998 Jul 23;339(4):229-34
references: 9673301
references: Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1642-8
references: 20466975
references: J Am Coll Cardiol. 2013 Jan 15;61(2):148-52
references: 23219296
references: Diabetes Care. 2009 Oct;32(10):1924-9
references: 19794004
references: J Lipid Res. 1992 Mar;33(3):333-42
references: 1569383
references: Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):150-9
references: 19229235
references: Diabetes Care. 1996 Jun;19(6):629-37
references: 8725863
references: Curr Opin Lipidol. 2000 Jun;11(3):253-60
references: 10882340
references: Diabetes Care. 2010 Apr;33(4):869-74
references: 20067955
references: J Lipid Res. 2007 Jun;48(6):1409-16
references: 17372331
references: Diabetologia. 2006 Apr;49(4):660-6
references: 16432708
references: PLoS One. 2011;6(11):e27208
references: 22073289
references: Circulation. 2012 Apr 24;125(16):1979-87
references: 22461416
references: Nat Med. 2007 Mar;13(3):340-7
references: 17322896
references: Cardiovasc Diabetol. 2012 Dec 27;11:156
references: 23270560
references: Arterioscler Thromb. 1993 Jul;13(7):1046-52
references: 8318506
references: Diabetes. 2012 Mar;61(3):659-64
references: 22315310
references: Atherosclerosis. 2011 Dec;219(2):510-8
references: 21862013
references: Clin Endocrinol (Oxf). 2010 Apr;72(4):481-8
references: 19673927
references: Curr Opin Lipidol. 2010 Aug;21(4):289-97
references: 20616715
references: Diabetes Res Clin Pract. 2010 Jan;87(1):98-107
references: 19913318
references: J Clin Invest. 2008 Feb;118(2):403-8
references: 18246189
references: Atheroscler Suppl. 2004 Oct;5(3):81-7
references: 15531279
references: N Engl J Med. 2007 Sep 27;357(13):1301-10
references: 17898099
references: Diabetes Care. 1998 Dec;21(12):2077-84
references: 9839097
references: Circulation. 2009 Apr 21;119(15):2103-11
references: 19349317
references: Acta Diabetol. 2013 Apr;50(2):277-81
references: 21997326
references: Diabetes. 1997 Jul;46(7):1207-13
references: 9200657
references: Am J Cardiol. 2001 Sep 20;88(6A):9H-15H
references: 11576520
references: Diabetes Care. 2004 Jun;27(6):1496-504
references: 15161808
references: J Am Coll Cardiol. 2005 Oct 18;46(8):1516-20
references: 16226177
references: Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K
references: 19068318
references: Diabetes Res Clin Pract. 2003 Jul;61 Suppl 1:S19-26
references: 12880691
references: Diabetes Obes Metab. 2009 Jun;11(6):534-43
references: 19175378
references: Diabetes Care. 2012 Dec;35(12):2600-6
references: 23139370
references: Lancet. 2010 Nov 13;376(9753):1670-81
references: 21067804
references: Nat Med. 2001 Jan;7(1):53-8
references: 11135616
references: Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1225-36
references: 18565848